G-CSF enhances the therapeutic potency of stem cells transplantation in spinal cord-injured rats

Regen Med. 2019 Jun;14(6):571-583. doi: 10.2217/rme-2018-0104. Epub 2019 May 22.

Abstract

Aim: The therapeutic effects of human wisdom teeth-derived neuronal stem cell (tNSC) cotreatment with granulocyte-colony-stimulating factor (G-CSF) were evaluated for contusion-induced spinal cord injury in rats. Materials & methods: 7 days after contusion, tNSCs were transplanted to the injury site and followed by G-CSF cotreatment for 5 days. Behavioral deficits were evaluated by the Basso, Beattie and Bresnahan test. The injury site was collected for immunohistochemistry analysis. Results: The Basso, Beattie and Bresnahan test significantly improved in the cotreated group compared with the tNSCs or G-CSF single treatment groups. However, inflammation indices did not differ among the three groups. In vitro experiment demonstrated that tNSCs express both G-CSF and its relevant receptor. G-CSF enhanced tNSC proliferation and neurotrophins secretion in vitro. Conclusion: This study demonstrated that G-CSF enhances neurotrophins secretion of tNSCs, and might help improving functional recovery from spinal cord injury in rats if they were given together.

Keywords: granulocyte-colony-stimulating factor; spinal cord injury; stem cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Heterografts
  • Humans
  • Male
  • Neural Stem Cells* / metabolism
  • Neural Stem Cells* / pathology
  • Neural Stem Cells* / transplantation
  • Rats
  • Rats, Long-Evans
  • Spinal Cord Injuries* / metabolism
  • Spinal Cord Injuries* / pathology
  • Spinal Cord Injuries* / physiopathology
  • Spinal Cord Injuries* / therapy
  • Stem Cell Transplantation*

Substances

  • Granulocyte Colony-Stimulating Factor